Gwyn Bebb, MD, PhD

Dr. Gwyn Bebb brings more than 30 years of clinical research experience across academia and the biotechnology industry, with a proven track record spanning both the CRO sector and drug development.

Prior to joining Premier, Gwyn served for two and a half years as Senior Vice President and Head of Oncology at a large CRO, where he led a global team of oncologists overseeing a broad portfolio of clinical trials across multiple cancer indications. Before that, as a Clinical Research Medical Director in Global Development in pharma, he advanced a bispecific T-cell engager into a confirmatory Phase 3 trial in small cell lung cancer.

Earlier in his career, Gwyn was a Professor in the Department of Medicine at the University of Calgary, Alberta, Canada. There, he directed the Clinical Trials Unit at the Tom Baker Cancer Centre and established a provincial lung cancer database to evaluate real-world patient outcomes in relation to molecular markers studied in his research laboratory.

Gwyn earned his undergraduate degree in Natural Sciences from the University of Cambridge, his medical degree from the University of Oxford, and a doctorate in molecular pathology from the University of British Columbia in Vancouver, Canada. He resides in Los Angeles, California.